Heart Failure
Medtronic Commences Clinical Trial of Innovative Delivery Technology for Heart Failure Patients with Implanted Cardiac Resynchronization Devices
Published in Medical Device Business Week, June 6th, 2007
Medtronic Inc. (NYSE:MDT) announced the first clinical implants in the United States of the Medtronic Attain Ability(TM) over-the-wire lead (Model 4196), a dual-electrode left ventricular (LV) lead for use in heart failure patients with cardiac resynchronization therapy (CRT) devices. These implantable devices are used to resynchronize the heart's ventricles to help pump blood more effectively through the body.
Placing a lead in the LV is widely recognized by physicians as the most challenging aspect of implanting CRT devices. Anatomic challenges can make it difficult to access and work within the coronary sinus to place a lead in the desired vein of the LV. The Attain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Alzheimer Disease
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting - Angiology
Luna Innovations Blood Circuit Monitor Receives FDA Clearance - Artificial Organs
HepaLife Announces Appointment of Senior Medical Device and Healthcare Executive to the Board of Directors - Artificial Organs
Renowned Biomedical Scientists Come to Tucson to Review the World's First and Only temporary Total Artificial Heart - Biomagnetics
Biomagnetics Diagnostics Engages Platinum Productions to Promote a Media Campaign with Nationwide Coverage - Biomedical Engineering
Cytyc Corporation Accepts Shares of Adeza Biomedical Corporation in Tender Offer and Commences Subsequent Offering Period - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
